Campylobacter Infection Introduced Following Fecal Microbiota Transplantation

Fecal microbiota transplantation is an evidence-based therapeutic option for recurrent infection, involving the transfer of healthy donor fecal material to restore gut microbial balance. Despite meticulous donor screening, , a prevalent cause of bacterial gastroenteritis, is not routinely tested, potentially impacting fecal microbiota transplant safety. We present a case of a female with recurrent infection treated with fecal microbiota transplantation, complicated by a subsequent infection. The emergence of post fecal microbiota transplantation underscores the importance of comprehensive donor screening protocols. Our case prompts a reevaluation of fecal microbiota transplantation safety measures and advocates for inclusive screening to enhance patient outcomes.